Literature DB >> 8717514

CD28/B7 system of T cell costimulation.

D J Lenschow1, T L Walunas, J A Bluestone.   

Abstract

T cells play a central role in the initiation and regulation of the immune response to antigen. Both the engagement of the TCR with MHC/Ag and a second signal are needed for the complete activation of the T cell. The CD28/B7 receptor/ligand system is one of the dominant costimulatory pathways. Interruption of this signaling pathway with CD28 antagonists not only results in the suppression of the immune response, but in some cases induces antigen-specific tolerance. However, the CD28/B7 system is increasingly complex due to the identification of multiple receptors and ligands with positive and negative signaling activities. This review summarizes the state of CD28/B7 immunobiology both in vitro and in vivo; summarizes the many experiments that have led to our current understanding of the participants in this complex receptor/ligand system; and illustrates the current models for CD28/B7-mediated T cell and B cell regulation. It is our hope and expectation that this review will provoke additional research that will unravel this important, yet complex, signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717514     DOI: 10.1146/annurev.immunol.14.1.233

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  603 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

3.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.

Authors:  S M Kaech; R Ahmed
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

Review 4.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 5.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 6.  Controlling mature CD4+ T cell responses.

Authors:  M E Ozaki; S R Webb
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

7.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 8.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

9.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 10.  Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.

Authors:  H Kobayashi; A A Horner; E Martin-Orozco; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.